SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001839882-24-027198
Filing Date
2024-08-29
Accepted
2024-08-29 07:02:39
Documents
20
Period of Report
2024-08-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-082924.htm   iXBRL 8-K 33657
2 PRESS RELEASE OF THE COMPANY, AUGUST 29, 2024 ex99-01.htm EX-99.01 21165
3 TWO CLINICAL TRIALS OF BEDTIME SUBLINGUAL CYCLOBENZAPRINE (TNX-102 SL) ex99-02.htm EX-99.02 1279
4 DEVELOPMENT OF THE AURORA PLATFORM TRIAL NETWORK ex99-03.htm EX-99.03 1222
5 INTEGRATING AUTOMATED HIGH-THROUGHPUT SCRATCH ASSAY AND CELL PAINTING ex99-04.htm EX-99.04 1276
9 GRAPHIC ex99-02_1.jpg GRAPHIC 3784159
10 GRAPHIC ex99-03_1.jpg GRAPHIC 3958031
11 GRAPHIC ex99-04_1.jpg GRAPHIC 5194597
  Complete submission text file 0001839882-24-027198.txt   17565281

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnxp-20240829.xsd EX-101.SCH 3024
7 XBRL LABEL FILE tnxp-20240829_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE tnxp-20240829_pre.xml EX-101.PRE 22365
22 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-082924_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 241258540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)